General Biologics
UEI: YX34DPZHLJN5
• CAGE: 89BR9
Overview
Awardee Type
Parent
Federal Capability Statement
We engage in corporate partnerships for therapeutic protein engineering, antibody humanization, fusion protein design and construction, extension of serum half-life, and biological insight.
Keywords
Biotechnology, Protein Engineering
Website
Headquarters
Cambridge, MA
United States
United States
Most Recent Award
May 1, 2023
Calculating
Federal contract and grant recipient
GENERAL BIOLOGICS INC
(UEI YX34DPZHLJN5, CAGE 89BR9)
is headquartered in Cambridge MA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in March 2016 and
federally registered in
February 2019.
Federal Award Analysis
General Biologics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
GENERAL BIOLOGICS INC
UEI
YX34DPZHLJN5
CAGE Code
89BR9
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 29, 2016
Initial Registration
Feb. 25, 2019
Last Registration
Oct. 28, 2024
Registration Activation
Oct. 28, 2024
Registration Expiration
Oct. 24, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No
People
Vendor contacts at General Biologics
Contract Awards
General Biologics prime contract awards
Subgrant Awards
General Biologics subgrant awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
General Biologics